Marwa E Elsherbiny

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Transforming Growth Factor

Respiratory Tract

Top Venues

Pharmaceuticals (Basel, Switzerland)

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Marwa E Elsherbiny, May Almukainzi, Eman Amer, Marwan Emara
Hyperlipidemia Increases Nalbuphine Brain Accumulation with Multiple Dosing without Affecting Its Analgesic Response-Its Respiratory Depression Potential Should Be Investigated in Future Studies. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Marwa E Elsherbiny, May Almukainzi, Eman Amer, Marwan Emara
Hyperlipidemia Increases Nalbuphine Brain Accumulation with Multiple Dosing without Affecting Its Analgesic Response-Its Respiratory Depression Potential Should Be Investigated in Future Studies. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Marwa E Elsherbiny, May Almukainzi, Eman Amer, Marwan Emara
Hyperlipidemia Increases Nalbuphine Brain Accumulation with Multiple Dosing without Affecting Its Analgesic Response-Its Respiratory Depression Potential Should Be Investigated in Future Studies. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Rehab Kamel, Engy M El Morsy, Marwa E Elsherbiny, Mahmoud Nour-Eldin
Chrysin promotes angiogenesis in rat hindlimb ischemia: Impact on PI3K/Akt/mTOR signaling pathway and autophagy. Drug development research 83 (5) (2022)
Ahmed S Kamel, Ahmed F Mohamed, Mostafa A Rabie, Marwa E Elsherbiny, Kawkab A Ahmed, Mahmoud M Khattab, Noha F Abdelkader
Experimental Evidence for Diiodohydroxyquinoline-Induced Neurotoxicity: Characterization of Age and Gender as Predisposing Factors. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)